Umbilical Cord Blood Banking Market Research Report by Storage, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Source: Media Outreach
SINGAPORE – Media OutReach – 3 March 2021 – Cordlife Group Limited, a consumer healthcare company announced today that the Ministry of Health has issued a license permitting the Company to launch OptiQ, a corneal lenticule banking service in Singapore. Cordlife is the first company in Asia to let patients undergoing refractive eye surgery using lenticule extraction method (e.g. SMILE) for myopia or astigmatism to cryopreserve their corneal lenticules for potential treatment of presbyopia and other ocular conditions in the future.
The technology behind OptiQ was invented by Professors Donald Tan and Jodhbir Mehta from Singapore Eye Research Institute (“SERI”), the research arm of Singapore National Eye Centre (“SNEC”).
Singapore launches first bank in Asia for eye surgery patients to freeze piece of corneal tissue for future use straitstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from straitstimes.com Daily Mail and Mail on Sunday newspapers.
Cord blood is the blood that remains in the umbilical cord and placenta after childbirth
bmrcFebruary 22, 2021 20
Cord Blood Banking Services Market is valued at USD 1,327.6 Million in 2018 and expected to reach USD 2,975.2 Million by 2025 with the CAGE of 12.20% over the forecast period.
The Detailed Market intelligence report on the Cord Blood Banking Services Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Cord Blood Banking Services Market place for the forecast 2019– 2025.
Scope of The Report:
Cord blood is the blood that remains in the umbilical cord and placenta after childbirth. Cord blood cells are the rich source of the stem cells and these stem cells are used to treat chronic diseases. Which includes immune system diseases, cancers, diabetes, and blood-related diseases these stem cells are collected from the nursing homes or hospitals and